Frovatriptan
Selective Serotonin (5ht1) Agonists
Sold as FROVA
- Drug class
- Selective Serotonin (5ht1) Agonists
- Availability
- Prescription only
- Routes
- Oral
- Markets covered
- 3
- Products on record
- 16
Overview
Frovatriptan is an active pharmaceutical ingredient in the Selective Serotonin (5ht1) Agonists group (N02CC). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 9 | April 10, 2026 |
| CA Canada | Health Canada | 6 | May 8, 2026 |
| US United States | FDA | 1 | January 28, 2026 |
GBUnited Kingdom· MHRA
9 products
Uses
Acute treatment of the headache phase of migraine attacks with or without aura. Frovatriptan is indicated in adults.
How to take
CACanada· Health Canada
6 products
Uses
FROVA (frovatriptan tablets) is indicated for the acute treatment of migraine attacks with or without aura in adults. FROVA is not intended for the prophylactic therapy of migraine or for the use in the management of hemiplegic, ophthalmoplegic or basilar migraine (see
How to take
USUnited States· FDA
1 product
Uses
1 INDICATIONS AND USAGE Frovatriptan succinate tablets are indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use • Use only if a clear diagnosis of migraine has been established. If a patient has no response for the first migraine attack treated with frovatriptan succinate tablets, reconsider the diagnosis of migraine before frovatriptan succinate tablets are administered to treat any subsequent attacks.
• Frovatriptan succinate tablets are not indicated for the prevention of migraine attacks. • Safety and effectiveness of frovatriptan succinate tablets have not been established for cluster headache. Frovatriptan succinate is a serotonin (5-HT 1B/1D ) receptor agonist (triptan) indicated for the acute treatment of migraine with or without aura in adults ( 1 ) Limitations of Use • Use only after a clear diagnosis of migraine has been established ( 1 ) • Not indicated for the prophylactic therapy of migraine ( 1 ) • Not indicated for the treatment of cluster headache ( 1 )
Drug interactions
Known interactions involving Frovatriptan. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL517180035 · revised January 24, 2025
- [2]Health Canada (DPD) · 02257084 · revised May 8, 2026
- [3]FDA DailyMed · 03a58215-dba7-4f… · revised January 28, 2026 [PDF]
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.